Dyna Ethambutol 400 mg FC tablets.
PDF Leaflet Revision Date: 06 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of tuberculosis in combination with other anti-tubercular medicines.
Dosage (summary)
Adults: 15 mg/kg daily; re-treatment: 25 mg/kg for 60 days, then 15 mg/kg.
Special Populations
- Renal impairment
- Elderly
- Children under 5 years
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; crosses placenta and excreted in breast milk.
Key Drug Interactions
- Neurotoxic medicines
- Aluminium containing antacids
Contraindications
- Hypersensitivity to ethambutol
- Optic neuritis
- Children under 5 years
Common side effects
- Visual disturbances
- Dizziness
- Nausea
- Headache
Counselling Points
- Monitor vision regularly
- Take with or without food
- Do not double dose if missed
Serious warnings
- Ocular toxicity may lead to irreversible blindness
- Careful use in renal impairment
Important Disclaimer
The Dyna Ethambutol 400 mg FC tablets. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
